KPC-producing Klebsiella pneumoniae (KPC-Kp) gut colonization is a major risk factor for developing systemic infections. Ceftazidime/avibactam could have a role as decolonization therapy in special situations PATIENTS AND METHODS: retrospective, observational, multicenter study. We compared KPC-Kp gut decolonization rate of ceftazidime/avibactam-based therapy (Group A) and other antimicrobial regimens (Group B) in patients with a KPC-Kp infection.

KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study

Bassetti, Matteo;Tascini, Carlo
2019-01-01

Abstract

KPC-producing Klebsiella pneumoniae (KPC-Kp) gut colonization is a major risk factor for developing systemic infections. Ceftazidime/avibactam could have a role as decolonization therapy in special situations PATIENTS AND METHODS: retrospective, observational, multicenter study. We compared KPC-Kp gut decolonization rate of ceftazidime/avibactam-based therapy (Group A) and other antimicrobial regimens (Group B) in patients with a KPC-Kp infection.
File in questo prodotto:
File Dimensione Formato  
Bassetti2019.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: Non pubblico
Dimensione 255.52 kB
Formato Adobe PDF
255.52 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11390/1148241
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact